IDEXX Laboratories, Inc. (IDXX)
676.04
+5.33
(+0.79%)
USD |
NASDAQ |
Nov 06, 16:00
677.73
+1.69
(+0.25%)
After-Hours: 20:00
IDEXX Laboratories Cash from Investing (Quarterly) : -248.10M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -248.10M |
| June 30, 2026 | -25.50M |
| March 31, 2026 | -33.54M |
| December 31, 2025 | -28.13M |
| September 30, 2025 | -44.87M |
| June 30, 2025 | -33.63M |
| March 31, 2025 | -29.61M |
| December 31, 2024 | -39.84M |
| September 30, 2024 | -27.37M |
| June 30, 2024 | -32.91M |
| March 31, 2024 | -106.94M |
| December 31, 2023 | -30.44M |
| September 30, 2023 | -27.84M |
| June 30, 2023 | -27.47M |
| March 31, 2023 | -39.51M |
| December 31, 2022 | -49.23M |
| September 30, 2022 | -49.20M |
| June 30, 2022 | -55.09M |
| March 31, 2022 | -41.84M |
| December 31, 2021 | -45.03M |
| September 30, 2021 | -49.68M |
| June 30, 2021 | -174.66M |
| March 31, 2021 | -24.59M |
| December 31, 2020 | -15.69M |
| September 30, 2020 | -19.46M |
| Date | Value |
|---|---|
| June 30, 2020 | -24.56M |
| March 31, 2020 | -49.67M |
| December 31, 2019 | -95.91M |
| September 30, 2019 | -37.33M |
| June 30, 2019 | -34.08M |
| March 31, 2019 | -38.21M |
| December 31, 2018 | -39.84M |
| September 30, 2018 | -54.22M |
| June 30, 2018 | -27.65M |
| March 31, 2018 | 260.31M |
| December 31, 2017 | -24.49M |
| September 30, 2017 | -41.49M |
| June 30, 2017 | -43.70M |
| March 31, 2017 | -29.01M |
| December 31, 2016 | -14.28M |
| September 30, 2016 | -22.95M |
| June 30, 2016 | -29.76M |
| March 31, 2016 | -23.80M |
| December 31, 2015 | -26.01M |
| September 30, 2015 | -54.81M |
| June 30, 2015 | -66.97M |
| March 31, 2015 | -160.62M |
| December 31, 2014 | -35.62M |
| September 30, 2014 | -23.45M |
| June 30, 2014 | -8.712M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -- |
| DexCom, Inc. | -76.70M |
| Abbott Laboratories | -385.00M |
| Intuitive Surgical, Inc. | 1.898B |
| Teleflex, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 449.72M |
| Cash from Financing (Quarterly) | -200.85M |
| Free Cash Flow | 1.296B |
| Free Cash Flow Per Share (Quarterly) | 5.323 |
| Free Cash Flow to Equity (Quarterly) | 543.90M |
| Free Cash Flow to Firm (Quarterly) | 427.65M |
| Free Cash Flow Yield | 2.40% |